Eccles R, Martensson K, Chen SC. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Current Medical Research and Opinion. April 2010, 26 (4): 889–899. PMID 20151787. S2CID 34728458. doi:10.1185/03007991003648015.
World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Eccles R, Martensson K, Chen SC. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Current Medical Research and Opinion. April 2010, 26 (4): 889–899. PMID 20151787. S2CID 34728458. doi:10.1185/03007991003648015.
Eccles R, Martensson K, Chen SC. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Current Medical Research and Opinion. April 2010, 26 (4): 889–899. PMID 20151787. S2CID 34728458. doi:10.1185/03007991003648015.